News Toleranzia AB

Equities

TOL

SE0007438577

Market Closed - Nasdaq Stockholm Other stock markets 11:29:43 2024-06-05 am EDT			5-day change	1st Jan Change
0.684 ^SEK	+3.95%		+5.56%	+59.81%

May. 20	Toleranzia AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 23	Toleranzia AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Toleranzia AB conducts successful safety study of TOL2 in blood samples from patients with myasthenia gravis	May. 31	AQ
Toleranzia : Annual General Meeting 2024 06 19 – Postal voting form	May. 28	PU
Toleranzia : Annual General Meeting 2024 06 19 – Proxy form	May. 28	PU
Toleranzia : Annual General Meeting 2024 06 19 – Annual Report 2023	May. 28	PU
Toleranzia : Annual General Meeting 2024 06 19 – Auditor’s Report 2023	May. 28	PU
Notice of Annual General Meeting in Toleranzia AB (publ)	May. 20	AQ
Toleranzia AB: Interim report first quarter 2024	May. 20	AQ
Toleranzia AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 20	CI
Toleranzia AB: Annual report for the financial year 2023	Apr. 30	AQ
Toleranzia AB receives loan commitment of SEK 20 million	Apr. 24	AQ
Toleranzia reports positive outcome from advisory meeting with the German Medicines Agency for the TOL2 development program	Mar. 18	AQ
Toleranzia AB – Year-End Report 2023	Feb. 23	AQ
Toleranzia AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 23	CI
Toleranzia AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
Toleranzia successfully completes GLP toxicology study of TOL2	Jan. 15	AQ
Toleranzia AB Successfully Completes GLP Toxicology Study of TOL2	Jan. 15	CI
Toleranzia AB starts production of finished drug product for clinical studies	Dec. 21	AQ
Toleranzia AB Starts Production of Completed Drug Product for Clinical Studies	Dec. 21	CI
Toleranzia AB presents Nomination Committee	Dec. 15	AQ
Toleranzia AB Announces Nomination Committee	Dec. 15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Toleranzia AB

Equities

TOL

SE0007438577

Summary

Filters